DEFERRED INCOME

6 Months Ended

Jun. 30, 2014

Deferred Revenue Disclosure [Abstract]

Deferred Revenue Disclosure [Text Block]

DEFERRED INCOME

Dollars in Millions	June 30, 2014		December 31, 2013
Upfront, milestone and other licensing receipts	$	885	$	970
Atripla* deferred revenue	461		468
Gain on sale-leaseback transactions	57		71
Diabetes business divestiture (Undelivered elements)	629		—
Other	100		16
Total deferred income	$	2,132	$	1,525
Current portion	$	1,090	$	756
Non-current portion	1,042		769

Further information pertaining to upfront, milestone and other licensing payments is described in “Note 3. Alliances” in the Company’s 2013 Form 10-K.

Amortization of deferred income was $174 million and $248 million for the six months ended June 30, 2014 and 2013, respectively.